Prohost Biotech
HomeArticlesTrick or TradeDevastated and Resurrected Good Biotech Firms: Theravance Biopharma
Trick or Trade
Premium

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

The Market Devastation and Resurrection of Good Biotech Firms Due to the market’s instability that we have been experiencing for a while now, we decided to look back at some biotech firms whose values...
P

Prohost Biotech

1 min read
3
0

Unlock Premium Content

This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.

Unlimited articles
Expert analysis
Research reports

Tags

Celldex Therapeutics (CLDX)
IVERIC bio (ISEE)
Theravance Biopharma (TBPH)

Comments (0)

Please sign in to join the discussion

Related Articles

Trick or Trade
Premium

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

BioNTech BioNTech ( BNTX ) announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan in patients with HER2-expressing, advanced endometrial cancer whos...
P

Prohost Biotech

Apr 17, 2026

1m
125
Trick or Trade
Premium

Zymeworks Inc Question and Answer

Zymeworks Inc Q & A Q: What’s the story about Zymeworks entering into a deal with Royalty Pharma? A: Zymeworks and Royalty Pharma have already entered into $250 Million Royalty-Backed Note Financing....
P

Prohost Biotech

Mar 12, 2026

1m
42
Trick or Trade
Premium

Milestone Receives FDA Approval of CARDAMYST™ as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia

Milestone in the NEWS MONTREAL and CHARLOTTE, Milestone ® ( MIST ) announced that the U.S. FDA approved its first commercial product, CARDAMYST™ (etripamil) nasal spray, a prescription medication for...
P

Prohost Biotech

Dec 16, 2025

1m
37